
Validea's Patient Investor model, which applies Warren Buffett's investment strategy, rates Amphenol Corp (APH) at 66%, falling short of the 80%+ threshold for investment interest. While APH demonstrates strong underlying fundamentals, passing criteria like earnings predictability, debt service, and free cash flow, its overall score is tempered by failures in the initial rate of return and expected return tests, suggesting its current valuation limits its appeal for a Buffett-style investor.
According to Validea's Patient Investor model, which emulates Warren Buffett's investment criteria, Amphenol Corp (APH) presents a mixed profile. The company scores a 66% rating, which is below the 80% threshold indicating strategic interest. This assessment highlights a clear divergence between the company's operational strength and its current market valuation. On one hand, APH demonstrates robust fundamentals, passing key tests for earnings predictability, debt service capacity, return on equity, return on total capital, free cash flow generation, and the effective use of retained earnings. These factors point to a high-quality, predictable, and well-managed business. On the other hand, the stock fails crucial valuation-based criteria, specifically the 'initial rate of return' and 'expected return' tests. This failure is the primary driver of the subdued overall score, suggesting that despite its fundamental quality, APH's current stock price is too high to offer the margin of safety and potential returns sought by a classic value investor.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
-0.10
Ticker Sentiment